- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT02901834
PainSquad+: A Smartphone App to Support Real-time Pain Management for Adolescents With Cancer
29 grudnia 2017 zaktualizowane przez: Jennifer Stinson, The Hospital for Sick Children
PainSquad+: A Smartphone App to Support Real-time Pain Management for Adolescents
Adolescents with cancer (AWC) are in a unique developmental stage that may mean pain characteristics, the impact of pain, and pain treatment outcomes are different in adolescents compared to children and adults.
In response, we will develop and test the PainSquad+ pain management smartphone app.
First, we will conduct usability testing to refine PainSquad+ so that it is useable, acceptable and understandable for AWC.
Secondly we will: (a) test the feasibility of conducting a large-scale PainSquad+ experiment and (b) begin to examine how effective PainSquad+ is at helping adolescents manage pain.
We hope that once developed and tested for effectiveness, PainSquad+ will improve pain treatment and ultimately quality of life in AWC.
Przegląd badań
Status
Zakończony
Warunki
Szczegółowy opis
Using a conservative estimate of 7 adolescents per cycle and 3 testing cycles, 21 adolescents will take part in usability testing of the PainSquad+ prototype.
Recruitment will be conducted in a single hematology/oncology division of a metropolitan and university-affiliated pediatric tertiary care center in Toronto, Canada.
This site hosts one of the largest cancer programs in North America, with approximately 350 new diagnoses each year.
Based on our previous research at this site, 72 ± 4% (M ± SD; range = 67-75%) of eligible AWC agreed to participate in similar studies (unpublished data).
Convenience sampling will be used to recruit eligible individuals.
The testing procedures will commence after eligibility is assessed, informed consent is obtained, and demographic and baseline outcome data are collected.
Inclusion criteria will be: (a) aged 12-18 years, (b) able to speak and read English, (c) actively undergoing cancer treatment on an in- or out-patient basis, (d) being at least 3 months from diagnosis and (d) having self-reported pain of any intensity in the week immediately prior to recruitment.
Exclusion criteria will be: (a) one or more major co-morbid (medical or psychiatric) conditions that would preclude use of a smartphone, and (b) palliative/end-of-life patients.
Typ studiów
Obserwacyjny
Zapisy (Rzeczywisty)
40
Kryteria uczestnictwa
Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.
Kryteria kwalifikacji
Wiek uprawniający do nauki
12 lat do 18 lat (Dziecko, Dorosły)
Akceptuje zdrowych ochotników
Nie
Płeć kwalifikująca się do nauki
Wszystko
Metoda próbkowania
Próbka bez prawdopodobieństwa
Badana populacja
Adolescents aged 12-18 years who have been diagnosed at least 2 months with cancer and have had pain in the past week.
Opis
Inclusion Criteria:
- aged 12-18 years,
- able to speak and read English
- actively undergoing cancer treatment on an in- or out-patient basis
- being at least 3 months from diagnosis
- having self-reported pain of any intensity in the week immediately prior to recruitment
Exclusion Criteria:
- one or more major co-morbid (medical or psychiatric) conditions that would preclude use of a smartphone
- palliative/end-of-life patients.
Plan studiów
Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.
Jak projektuje się badanie?
Szczegóły projektu
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Accrual and attrition rates
Ramy czasowe: 12 months
|
The Cancer Pain Management App Recruitment Log has been designed to record data related to the number of eligible adolescents per recruitment day, reasons for ineligibility, and reasons for nonparticipation.
The Cancer Pain Management App Activity Log has been designed to record data on attrition (occurrence/reasons for attrition), as well as technical difficulties, adherence and outcome measure completion.
|
12 months
|
|
Technical difficulties
Ramy czasowe: 12 months
|
The occurrence and description of technical problems will be recorded on the Cancer Pain Management App Activity Log.
|
12 months
|
|
Acceptability
Ramy czasowe: 12 months
|
The Acceptability E-Scale (AES) ascertains perceptions related to how helpful, difficult, and enjoyable e-based programs are to use, how understandable questions are, and how acceptable the time invested in reporting was (Wu, Johnson, Schepp, & Berry, 2011).
For the purpose of the present study, the wording of the AES will be slightly modified.
Specifically, the words "computer program" will be changed to "app" and open-ended questions regarding study acceptability will be added.
|
12 months
|
|
Adherence
Ramy czasowe: 12 months
|
Measured as the percentage of pain reports received on the secure server.
An RA will sign onto the server and extract data logged by AWC on Day 29 to calculate adherence (100% when 28/28 morning and evening reports are completed).
These data will be recorded on the Cancer Pain Management App Activity Log.
|
12 months
|
|
Outcome measure feasibility
Ramy czasowe: 12 months
|
Measured as the percentage of completed questionnaires at baseline and study completion.
An RA will sign onto the server and extract data logged by AWC on Day 29 to calculate the percentage of completed questionnaires (100% when all questionnaires are completed).
These data will be recorded on the Cancer Pain Management App Activity Log.
|
12 months
|
|
Pain intensity
Ramy czasowe: 12 months
|
Measured using the pain intensity items (current pain intensity and worst, average, and least pain intensity in the previous week) of the Brief Pain Inventory (BPI).
The BPI is considered the standard for clinical and research use in cancer patients (Mathias et al., 2011).
Each item is rated numerically from 0-10.
Individual scores on each of the 4 items may be summed and to provide a composite pain intensity score.
Individual and summary scores will be used in our analyses.
Validity and reliability have been well-established in adults with cancer and the intensity sub-scale has been used successfully in AWC (Ameringer, 2010).
|
12 months
|
|
Pain interference
Ramy czasowe: 12 months
|
The Patient Reported Outcomes Measurement Information System Pediatric (PROMIS) Pain Interference Short-form Scale is an 8-item scale describing how pain restricts daily activities related to physical, psychological, and social functioning, as well as sleep, school, and enjoyment of life.
Each item is scored on a 5-point Likert response scale and totaling the scores generates a summary score, which will be used in our analyses.
Construct validity has been established in AWC (Hinds et al., 2013).
|
12 months
|
|
Health-related quality of life (HRQL)
Ramy czasowe: 12 months
|
The Pediatric Quality of Life Inventory (PedsQL) 4.0 is a 23-item generic HRQL scale not specific to pain.
It is comprised of physical, emotional, social and school functioning subscales with each subscale containing 5 to 8 items.
PedsQL4.0 is a reliable and valid measure of HRQL in AWC (Varni, Burwinkle, Katz, Meeske, & Dickinson, 2002).
We will use age-appropriate versions of PedsQL4.0 (i.e., appropriate item wording for 12 and 13-18 year olds).
Total and subscale scores will be used in analyses.
|
12 months
|
|
Self-efficacy
Ramy czasowe: 12 months
|
The Sherer's General Self-Efficacy Scale (GSES) is a 17-item scale that measures general belief in personal competence and has been used in children as young as 10 years old.
Each item is scored on a 5-point Likert scale.
Item scores are summed to provide an overall self-efficacy score to be used in analyses.
The psychometric properties of the measure have been demonstrated in AWC (Hinds et al., 2000).
|
12 months
|
|
Healthcare utilization
Ramy czasowe: 12 months
|
Healthcare utilization related to pain will be examined as the number of visits/calls to primary care provider, emergency room visits, oncology clinic visits and hospitalizations (i.e., bed days of care).
RN calls will not be included in healthcare utilization analyses.
Data will be collected using adolescent self-report and medical health records (by site specific RAs at end of study).
|
12 months
|
Współpracownicy i badacze
Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.
Sponsor
Śledczy
- Główny śledczy: Jennifer Stinson, RN, PhD, The Hospital for Sick Children
Publikacje i pomocne linki
Osoba odpowiedzialna za wprowadzenie informacji o badaniu dobrowolnie udostępnia te publikacje. Mogą one dotyczyć wszystkiego, co jest związane z badaniem.
Publikacje ogólne
- Jibb LA, Cafazzo JA, Nathan PC, Seto E, Stevens BJ, Nguyen C, Stinson JN. Development of a mHealth Real-Time Pain Self-Management App for Adolescents With Cancer: An Iterative Usability Testing Study [Formula: see text]. J Pediatr Oncol Nurs. 2017 Jul/Aug;34(4):283-294. doi: 10.1177/1043454217697022. Epub 2017 Apr 4.
- Jibb LA, Stevens BJ, Nathan PC, Seto E, Cafazzo JA, Johnston DL, Hum V, Stinson JN. Implementation and preliminary effectiveness of a real-time pain management smartphone app for adolescents with cancer: A multicenter pilot clinical study. Pediatr Blood Cancer. 2017 Oct;64(10). doi: 10.1002/pbc.26554. Epub 2017 Apr 19.
Daty zapisu na studia
Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.
Główne daty studiów
Rozpoczęcie studiów
1 kwietnia 2015
Zakończenie podstawowe (Rzeczywisty)
1 kwietnia 2016
Ukończenie studiów (Rzeczywisty)
1 maja 2016
Daty rejestracji na studia
Pierwszy przesłany
12 września 2016
Pierwszy przesłany, który spełnia kryteria kontroli jakości
14 września 2016
Pierwszy wysłany (Oszacować)
15 września 2016
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
3 stycznia 2018
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
29 grudnia 2017
Ostatnia weryfikacja
1 grudnia 2017
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 100045124
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .